{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:08:11Z","timestamp":1790226491909,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127770","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:45:06Z","timestamp":1758627906000},"page":"127770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa"],"prefix":"10.1016","volume":"64","author":[{"given":"Cari","family":"van Schalkwyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Meyer-Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithabiso","family":"Masuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Rangaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thato","family":"Chidarikire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithembile","family":"Dlamini-Nqeteko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127770_bb0005","doi-asserted-by":"crossref","unstructured":"Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah AS V, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health [Internet] 2021;9(2):e161\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33212031.","DOI":"10.1016\/S2214-109X(20)30459-9"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127770_bb0020","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ijc.33716","article-title":"Modelling the impact of prevention strategies on cervical cancer incidence in South Africa","volume":"149","author":"van Schalkwyk","year":"2021","journal-title":"Int J Cancer"},{"issue":"10224","key":"10.1016\/j.vaccine.2025.127770_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127770_bb0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/ijc.28425","article-title":"Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa","volume":"134","author":"Denny","year":"2014","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127770_bb0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/IGC.0000000000000422","article-title":"Unique human papillomavirus-type distribution in south African women with invasive cervical cancer and the effect of human immunodeficiency virus infection","volume":"25","author":"van Aardt","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127770_bb0055","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djaa010","article-title":"Durability of cross-protection by different schedules of the bivalent HPV vaccine: the CVT trial","volume":"112","author":"Tsang","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127770_bb0060","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S1473-3099(20)30860-4","article-title":"Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis","volume":"21","author":"Drolet","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127770_bb0065","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jech-2020-216305","article-title":"Cost-effectiveness of extending the HPV vaccination to boys: a systematic review","volume":"75","author":"Linertov\u00e1","year":"1978","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2025.127770_bb0070","article-title":"Estimating the effect of HIV on cervical cancer elimination in South Africa: comparative modelling of the impact of vaccination and screening","volume":"54","author":"Boily","year":"2022","journal-title":"EClinicalMedicine [Internet]"},{"issue":"32","key":"10.1016\/j.vaccine.2025.127770_bb0075","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1016\/j.vaccine.2017.12.078","article-title":"Evidence for single-dose protection by the bivalent HPV vaccine\u2014review of the Costa Rica HPV vaccine trial and future research studies","volume":"36","author":"Kreimer","year":"2018","journal-title":"Vaccine"},{"issue":"97","key":"10.1016\/j.vaccine.2025.127770_bb0080","first-page":"645","article-title":"The World Health Organization. Human papillomavirus vaccines: WHO position paper, December 2022. Weekly Epidemiological Record [Internet]","volume":"50","year":"2022"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127770_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/QAI.0000000000002927","article-title":"The effect of HIV programs in South Africa on national HIV incidence trends, 2000-2019","volume":"90","author":"Johnson","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"67","key":"10.1016\/j.vaccine.2025.127770_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jncimonographs\/lgae032","article-title":"HPV16\/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial","volume":"2024","author":"Porras","year":"2024","journal-title":"JNCI Monographs"},{"key":"10.1016\/j.vaccine.2025.127770_bb0100","article-title":"State-of-the-science of human papillomavirus vaccination in women with human immunodeficiency virus: summary of a scientific workshop","volume":"35","author":"Schuind","year":"2023","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.vaccine.2025.127770_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101585","article-title":"Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: a systematic review and meta-analysis","volume":"52","author":"Staadegaard","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"48","key":"10.1016\/j.vaccine.2025.127770_bb0110","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1016\/j.vaccine.2013.09.032","article-title":"Safety and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study","volume":"31","author":"Denny","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127770_bb0115","first-page":"429","article-title":"Quantifying the burden of disease: the technical basis for disability-adjusted life years","volume":"72","author":"Murray","year":"1994","journal-title":"Bull World Health Organ"},{"issue":"10258","key":"10.1016\/j.vaccine.2025.127770_bb0120","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127770_bb0125","unstructured":"Statistics South Africa. https:\/\/www.statssa.gov.za\/?page_id=1854&PPN=P0141 (Last Accessed: October 2024). 2024. Consumer Price Index."},{"key":"10.1016\/j.vaccine.2025.127770_bb0130","unstructured":"United Nations. https:\/\/treasury.un.org\/operationalrates\/OperationalRates.php#S (Last Accessed: 21 February 2025). 2025. UN Operational Rates of Exchange."},{"key":"10.1016\/j.vaccine.2025.127770_bib176","doi-asserted-by":"crossref","unstructured":"Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, et al. Cost-effectiveness of cervical cancer screening in women living with HIV in South Africa: A mathematical modeling study. J Acquir Immune Defic Syndr (1988). 2018;79(2):195\u2013205. doi: 10.1097\/QAI.0000000000001778.","DOI":"10.1097\/QAI.0000000000001778"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127770_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0141969","article-title":"Costs and cost effectiveness of three approaches for cervical cancer screening among HIV-positive women in Johannesburg, South Africa","volume":"10","author":"Lince-Deroche","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127770_bb0135","author":"Carter"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127770_bb0145","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/heapol\/czz152","article-title":"Estimating a cost-effectiveness threshold for health care decision-making in South Africa","volume":"35","author":"Edoka","year":"2020","journal-title":"Health Policy Plan"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127770_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233499","article-title":"Cost-effectiveness evaluations of the 9-valent human papillomavirus (HPV) vaccine: evidence from a systematic review","volume":"15","author":"Mahumud","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127770_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106836","article-title":"Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two east African countries","volume":"9","author":"Kiatpongsan","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127770_bb0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40261-022-01138-6","article-title":"Cost-effectiveness of bivalent, Quadrivalent, and Nonavalent HPV vaccination in South Africa","volume":"42","author":"Michaeli","year":"2022","journal-title":"Clin Drug Investig"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2025.127797","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:50:14Z","timestamp":1769025014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"alternative-id":["S0264410X25010679"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127770","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127770"}}